MS Patient’s Pick of the Week’s News: Stem Cells, Cognitive, Gilenya, Tecfidera, Zinbryta
Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Clinical Trial Supports Stem Cell Transplants to Treat RMS Patients with High Disease Activity It’s no secret to readers of this column and, indeed, to the wider MS community, that I am convinced…